Fig. 3From: A cross-sectional survey on the early impact of COVID-19 on the uptake of decentralised trial methods in the conduct of clinical trialsPercentage of trials that were conducted fully decentralised prior to COVID-19, and percentage of trials that changed to fully decentralised as a consequence of COVID-19. *Respondents that did not answer this question are left blank in figureBack to article page